Cargando…
The CLL comorbidity index in a population-based cohort: a tool for clinical care and research
The chronic lymphocytic leukemia comorbidity index (CLL-CI) is an efficient, CLL-specific tool derived from the Cumulative Illness Rating Scale. The CLL-CI is based on the assessment of the organ systems found to be most strongly associated with event-free survival (EFS) in CLL: vascular, upper gast...
Autores principales: | Rotbain, Emelie C., Gordon, Max J., Vainer, Noomi, Frederiksen, Henrik, Hjalgrim, Henrik, Danilov, Alexey V., Niemann, Carsten U. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Hematology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9043948/ https://www.ncbi.nlm.nih.gov/pubmed/35008098 http://dx.doi.org/10.1182/bloodadvances.2021005716 |
Ejemplares similares
-
Healthcare Utilization and Comorbidity in Chronic Lymphocytic Leukemia
por: Rotbain, Emelie C, et al.
Publicado: (2021) -
CLL-IPI applied in Binet A CLL: a nationwide cohort study
por: Rotbain, Emelie C., et al.
Publicado: (2022) -
Outcomes of patients with CLL sequentially resistant to both BCL2 and BTK inhibition
por: Lew, Thomas E., et al.
Publicado: (2021) -
Enrichment of BTK Leu528Trp mutations in patients with CLL on zanubrutinib: potential for pirtobrutinib cross-resistance
por: Blombery, Piers, et al.
Publicado: (2022) -
Single-cell sequencing demonstrates complex resistance landscape in CLL and MCL treated with BTK and BCL2 inhibitors
por: Thompson, Ella R., et al.
Publicado: (2022)